Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.
about
Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort studyDo needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidencePredictors of accidental fatal drug overdose among a cohort of injection drug usersA complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesGenome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.Some aspects of the natural history of HIV infection.Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.Suicide among heroin users: rates, risk factors and methods.Examining non-AIDS mortality among people who inject drugs.Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitionsFactors associated with premature mortality among young injection drug users in VancouverHIV infection and risk of overdose: a systematic review and meta-analysisThe social determinants of emergency department and hospital use by injection drug users in Canada.Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.Mortality among people who inject drugs: a systematic review and meta-analysis.Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose?Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian settingUnderstanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada.An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.HIV and hepatitis C among injecting drug users.Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration.Mortality risk among new onset injection drug users.Mortality Trends among Cocaine Users Treated between 1989 and 2013 in Northern Italy: Results of a Longitudinal Study.Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic.Mortality, causes of death and risk factors for death among primary amphetamine users in the Swedish criminal justice system.An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.Drug-related mortality and its impact on adult mortality in eight European countriesHospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999Increased Frequency of Overdose Deaths Among HIV-Infected Injection Drug Users
P2860
Q24804881-B5F2A157-B1CB-4BC9-B1D5-814DCEE446C9Q28249288-A2B9F79D-D1D8-4A73-8EFB-31A0F3FDBF20Q28366398-9C19E37B-67EE-4822-A9A7-CD584DFE50EDQ28483747-C08D39A3-5A6E-43D4-ABC8-75C1F30A4174Q33979751-7808D92B-4163-46C5-AAFB-518FABF55FC2Q34018002-EC7D9998-A53A-4778-B42B-50E6B6DCC46BQ34103196-189411BA-BDA0-44FD-B9B6-8B5ED597E2A1Q34157262-BBEC6693-3752-412F-AAE7-5F05D996237CQ34585154-93EF104B-A97E-4F6F-95E1-EF1ACCE76D88Q35081725-0C57C0B4-C9C1-4B81-90ED-1D90D8BA3E79Q35404956-60EA0E88-9472-46FA-AEE8-141027881B2FQ35585416-E2F7E441-B88C-43CA-8B68-36985FCE74A8Q35898498-2E59F5B6-B5E3-447E-B9AB-D1B38B3F6902Q36274713-4A2C7CD7-8374-4812-BDC6-49CD0819B1B7Q36492802-F9E0A255-DDA5-4FDA-B761-8E4DB4374F5AQ36706977-E2320FF0-4ABE-457F-8317-934C60C0E9ECQ36856141-65269DA5-E027-4F8A-8F72-13262C6994FEQ37373198-A79D124B-ACE4-4682-817F-67D9C21292F4Q37661224-BEA430DE-2A57-4B65-960A-A4F56A57B4E2Q38473638-59781B05-FBFB-4233-BEB5-34CBAE42BBC0Q39848406-9D2E7FF4-038E-4F5F-B70D-CA16355869B1Q41650208-89BF775F-774B-40EB-9973-7EFE414CDA84Q42605999-616C522B-592B-4F5C-AF94-CEA698CCC93EQ42757973-FAEF768E-41FA-4794-A40C-E916D8D8747BQ43966069-BFF0BDD6-7CE6-4F0A-991B-6527A1C0AEB7Q46921682-04AA8146-DD30-40FE-817C-4324C8A0DD70Q47635954-366EBF65-677B-44C3-B0FF-93C3C3754B3CQ48229008-26F02851-D35B-4F16-91C7-17EF7445748DQ51024346-F7E01E6E-3E9A-4192-BD9A-7AEE5B2564A4Q51212356-848C10B2-55A1-4C95-BE03-4D122951B0EEQ52281324-3C8B03BF-06A4-4C41-86EB-D4993A661199Q57209662-80DD5AD0-F55B-4479-B9C5-88361A8B124DQ58266382-F93A4645-DB39-405E-BD43-C26B770A11E3Q58289856-6009D767-B25F-457E-BCAD-6151B273B2BC
P2860
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Predictors of mortality in the ...... e and HIV-negative drug users.
@en
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus
@nl
type
label
Predictors of mortality in the ...... e and HIV-negative drug users.
@en
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus
@nl
prefLabel
Predictors of mortality in the ...... e and HIV-negative drug users.
@en
Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus
@nl
P2093
P1476
Predictors of mortality in the ...... e and HIV-negative drug users.
@en
P2093
Coutinho RA
Mientjes GH
van Ameijden EJ
van Haastrecht HJ
van den Hoek JA
P304
P356
10.1093/OXFORDJOURNALS.AJE.A008752
P407
P577
1996-02-01T00:00:00Z